Work

Single- and Multiple-Dose Pharmacokinetic, Safety, and Tolerability Profiles of Olanzapine Long-Acting Injection: An Open-Label, Multicenter, Nonrandomized Study in Patients With Schizophrenia

Year: 2013

Type: article

Study design: Clinical Trial

Source: Clinical Therapeutics

DOI: 10.1016/j.clinthera.2013.09.023

Authors: Malcolm Mitchell, Prajakti Kothare, Richard Bergstrom, Fangyi Zhao, Kai Yu Jen, Daniel Walker, Jason Johnson, David McDonnell

Institutions: Eli Lilly (United States), Indiana University School of Medicine

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Eli Lilly and Company

OpenAlex ID: W1984704903

FWCI: 1.389

Cites: 25

Cited by: 34

Related to: 10